Viewing Study NCT03295266


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2025-12-28 @ 12:14 AM
Study NCT ID: NCT03295266
Status: TERMINATED
Last Update Posted: 2019-11-13
First Post: 2017-09-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Single-Dose Pharmacokinetics of MK-3866 in Participants With Hepatic Impairment (MK-3866-006)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-12-19
Start Date Type: ACTUAL
Primary Completion Date: 2018-03-15
Primary Completion Date Type: ACTUAL
Completion Date: 2018-03-15
Completion Date Type: ACTUAL
First Submit Date: 2017-09-25
First Submit QC Date: None
Study First Post Date: 2017-09-27
Study First Post Date Type: ACTUAL
Results First Submit Date: 2019-10-22
Results First Submit QC Date: None
Results First Post Date: 2019-11-13
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-10-22
Last Update Post Date: 2019-11-13
Last Update Post Date Type: ACTUAL